Fred E Cooperrider

Array ( [id] => 4189531 [patent_doc_number] => 06043030 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Cell-cycle regulatory proteins, and uses related thereto' [patent_app_type] => 1 [patent_app_number] => 8/581918 [patent_app_country] => US [patent_app_date] => 1996-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 38804 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/043/06043030.pdf [firstpage_image] =>[orig_patent_app_number] => 581918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3910056 [patent_doc_number] => 06001648 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Optimized minizymes and miniribozymes and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/574396 [patent_app_country] => US [patent_app_date] => 1995-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 20112 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001648.pdf [firstpage_image] =>[orig_patent_app_number] => 574396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4176251 [patent_doc_number] => 06037121 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'DNA sequence encoding a tumor suppressor gene' [patent_app_type] => 1 [patent_app_number] => 8/569721 [patent_app_country] => US [patent_app_date] => 1995-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9088 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037121.pdf [firstpage_image] =>[orig_patent_app_number] => 569721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356029 [patent_doc_number] => 06190892 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Microbial production of indigo' [patent_app_type] => 1 [patent_app_number] => 8/560729 [patent_app_country] => US [patent_app_date] => 1995-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 11 [patent_no_of_words] => 12058 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190892.pdf [firstpage_image] =>[orig_patent_app_number] => 560729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3722400 [patent_doc_number] => 05672501 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Base-modified enzymatic nucleic acid' [patent_app_type] => 1 [patent_app_number] => 8/541365 [patent_app_country] => US [patent_app_date] => 1995-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 39 [patent_no_of_words] => 15106 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672501.pdf [firstpage_image] =>[orig_patent_app_number] => 541365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808515 [patent_doc_number] => 05831051 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Receptor for peptide hormones involved in energy homeostasis, and method and compositions for use thereof' [patent_app_type] => 1 [patent_app_number] => 8/538816 [patent_app_country] => US [patent_app_date] => 1995-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 16137 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831051.pdf [firstpage_image] =>[orig_patent_app_number] => 538816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4062084 [patent_doc_number] => 05866411 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Retroviral vector, a replication system for said vector and avian or mammalian cells transfected with said vector' [patent_app_type] => 1 [patent_app_number] => 8/525849 [patent_app_country] => US [patent_app_date] => 1995-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 7726 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866411.pdf [firstpage_image] =>[orig_patent_app_number] => 525849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759232 [patent_doc_number] => 05851826 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Helper virus-free herpesvirus vector packaging system' [patent_app_type] => 1 [patent_app_number] => 8/508088 [patent_app_country] => US [patent_app_date] => 1995-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 20 [patent_no_of_words] => 10097 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851826.pdf [firstpage_image] =>[orig_patent_app_number] => 508088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833359 [patent_doc_number] => 05814620 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Inhibition of neovascularization using vegf-specific oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/501356 [patent_app_country] => US [patent_app_date] => 1995-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 11173 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814620.pdf [firstpage_image] =>[orig_patent_app_number] => 501356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185128 [patent_doc_number] => 06159946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells' [patent_app_type] => 1 [patent_app_number] => 8/481341 [patent_app_country] => US [patent_app_date] => 1995-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 9270 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159946.pdf [firstpage_image] =>[orig_patent_app_number] => 481341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320507 [patent_doc_number] => 06331390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Cell-cycle regulatory proteins, and uses related thereto' [patent_app_type] => 1 [patent_app_number] => 8/497214 [patent_app_country] => US [patent_app_date] => 1995-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 39417 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331390.pdf [firstpage_image] =>[orig_patent_app_number] => 497214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992198 [patent_doc_number] => 05985620 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'TNF-.alpha. Ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/428252 [patent_app_country] => US [patent_app_date] => 1995-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 47 [patent_no_of_words] => 13373 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985620.pdf [firstpage_image] =>[orig_patent_app_number] => 428252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322412 [patent_doc_number] => 07517644 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-04-14 [patent_title] => 'Method and compositions for cellular reprogramming' [patent_app_type] => utility [patent_app_number] => 08/472801 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29306 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517644.pdf [firstpage_image] =>[orig_patent_app_number] => 08472801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4060506 [patent_doc_number] => 05866318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Inhibition of phospholipase A.sub.2 to reduce neuronal cell death' [patent_app_type] => 1 [patent_app_number] => 8/476463 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 17 [patent_no_of_words] => 12168 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866318.pdf [firstpage_image] =>[orig_patent_app_number] => 476463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596288 [patent_doc_number] => 06492365 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Microsomal triglyceride transfer protein' [patent_app_type] => B1 [patent_app_number] => 08/486929 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 46527 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492365.pdf [firstpage_image] =>[orig_patent_app_number] => 08486929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013046 [patent_doc_number] => 05962633 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Cytotoxic T-lymphocyte antigen as cysteine protease inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/485937 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 8879 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962633.pdf [firstpage_image] =>[orig_patent_app_number] => 485937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3812031 [patent_doc_number] => 05789197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Microsomal triglyceride transfer protein' [patent_app_type] => 1 [patent_app_number] => 8/486924 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 43966 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789197.pdf [firstpage_image] =>[orig_patent_app_number] => 486924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658969 [patent_doc_number] => 05656431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Platelet-activating factor acetylhydrolase' [patent_app_type] => 1 [patent_app_number] => 8/483232 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 25991 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656431.pdf [firstpage_image] =>[orig_patent_app_number] => 483232 [rel_patent_id] =>[rel_patent_doc_number] =>)